Mg 5-Sulfat Amp. Drossapharm Gmbh

Magnesium sulfate, the active ingredient in Mg 5-Sulfat Amp. Drossapharm Gmbh, is a magnesium salt presented as an ampoule for injection for intramuscular and intravenous use. It is employed to correct low magnesium levels and to manage obstetric and cardiac emergencies. GNH USA supplies Mg 5-Sulfat Amp. Drossapharm Gmbh as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Magnesium sulfate is used in clinical situations that require rapid electrolyte correction or vascular smooth‑muscle relaxation. - Hypomagnesemia: restores normal serum magnesium concentrations. - Eclampsia and pre‑eclampsia: prevents seizures and stabilises blood pressure in pregnant patients. - Cardiac arrhythmias (e.g., torsades de pointes): helps normalize cardiac rhythm. - Constipation: acts as an osmotic laxative to promote bowel movements.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Flushing or warmth at the injection site - Nausea or vomiting - Headache - Hypotension - Dizziness - Muscle weakness

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension or cardiovascular collapse - Hypermagnesemia leading to cardiac arrest - Anaphylactic reaction - Tissue necrosis at the injection site - Cardiac arrhythmias due to excessive magnesium levels

When using magnesium sulfate, clinicians should consider patient‑specific factors and monitor for complications. - Renal impairment: assess serum magnesium and adjust dose accordingly. - Cardiac disease: use cautiously in patients with conduction abnormalities. - Neuromuscular disorders: avoid or monitor in myasthenia gravis. - Pregnancy: evaluate risk‑benefit, especially in the third trimester. - Concomitant calcium channel blockers: monitor for additive hypotensive effects. - Store below 25°C: keep in original packaging, protect from moisture and light.

Magnesium sulfate can interact with several medicines, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - Calcium channel blockers: additive vasodilatory and hypotensive actions. - Neuromuscular blocking agents: prolonged muscle relaxation. - Other magnesium‑containing products: risk of hypermagnesemia.

Moderate Interactions (Monitor Closely): - Loop diuretics: increased renal magnesium loss. - ACE inhibitors or ARBs: potential impact on renal function. - Certain antibiotics (e.g., tetracyclines): may form complexes, reducing efficacy when given concurrently.